Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01284504 · ClinicalTrials.gov registry record · NA
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01284504: Clinical Trial NA study, sponsored by Stanford University.
NCT01284504 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01284504, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The proposed study aims to investigate how the administration of a drug known to reduce inflammation in humans, Celecoxib, will effect the peri-operative inflammatory response of a patient undergoing primary tumor resection surgery for colon cancer. The proposed project is an exploratory study, and will use data from blood samples and tumor samples to attempt to elucidate the immune and inflammatory response in colon cancer patients undergoing primary resection of their tumors.
Interventions
- DRUG Celecoxib
- OTHER placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01284504
The ClinicalTrials.gov registry entry for NCT01284504 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Celecoxib is the first listed.
NCT01284504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01284504 about?
NCT01284504 is a clinical study titled "Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer". The proposed study aims to investigate how the administration of a drug known to reduce inflammation in humans, Celecoxib, will effect the peri-operative inflammatory response of a patient undergoing primary tumor resection surgery for colon cancer. The proposed project is an exploratory study, and ...
What is the current status of trial NCT01284504?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2011-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01284504?
The interventions under investigation include: Celecoxib (DRUG), placebo (OTHER).
Who is sponsoring clinical trial NCT01284504?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.